| Tunable antibacterial coatings that support mammalian cell growth K Vasilev, V Sah, K Anselme, C Ndi, M Mateescu, B Dollmann, P Martinek, ... Nano letters 10 (1), 202-207, 2010 | 182 | 2010 |
| Molecular profiling of driver events in metastatic uveal melanoma J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ... Nature communications 11 (1), 1894, 2020 | 123 | 2020 |
| The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma L Ny, H Jespersen, J Karlsson, S Alsén, S Filges, C All-Eriksson, ... Nature communications 12 (1), 5155, 2021 | 110 | 2021 |
| Antibacterial surfaces by adsorptive binding of polyvinyl-sulphonate-stabilized silver nanoparticles K Vasilev, VR Sah, RV Goreham, C Ndi, RD Short, HJ Griesser Nanotechnology 21 (21), 215102, 2010 | 105 | 2010 |
| Early stages of growth of plasma polymer coatings deposited from nitrogen‐and oxygen‐containing monomers K Vasilev, A Michelmore, P Martinek, J Chan, V Sah, HJ Griesser, ... Plasma Processes and Polymers 7 (9‐10), 824-835, 2010 | 103 | 2010 |
| Surface Morphology in the Early Stages of Plasma Polymer Film Growth from Amine‐Containing Monomers A Michelmore, P Martinek, V Sah, RD Short, K Vasilev Plasma processes and polymers 8 (5), 367-372, 2011 | 91 | 2011 |
| The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment E Poon, S Mullins, A Watkins, GS Williams, JO Koopmann, G Di Genova, ... Journal for Immunotherapy of Cancer 5, 1-14, 2017 | 74 | 2017 |
| Toxicology study of single-walled carbon nanotubes and reduced graphene oxide in human sperm W Asghar, H Shafiee, V Velasco, VR Sah, S Guo, R El Assal, F Inci, ... Scientific Reports 6 (1), 1-11, 2016 | 66 | 2016 |
| Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer A Revenko, LS Carnevalli, C Sinclair, B Johnson, A Peter, M Taylor, ... Journal for Immunotherapy of Cancer 10 (4), 2022 | 50 | 2022 |
| Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression A Borodovsky, Y Wang, M Ye, JC Shaw, KF Sachsenmeier, N Deng, ... Cancer Research 77 (13_Supplement), 5580-5580, 2017 | 29 | 2017 |
| Inhibition of A2AR by AZD4635 induces anti-tumor immunity alone and in combination with anti-PD-L1 in preclinical models A Borodovsky, Y Wang, M Ye, JC Shaw, K Sachsenmeier, N Deng, ... Cancer Research 78 (13_Supplement), 3751-3751, 2018 | 16 | 2018 |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma VR Sah, J Karlsson, H Jespersen, MF Lindberg, LM Nilsson, L Ny, ... Melanoma Research 32 (4), 241-248, 2022 | 15 | 2022 |
| Bacteria inside semiconductors as potential sensor elements: biochip progress VR Sah, RE Baier Sensors 14 (6), 11225-11244, 2014 | 12 | 2014 |
| Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ... bioRxiv, 742023, 2019 | 4 | 2019 |
| Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro M Olsson, P Larsson, J Johansson, VR Sah, TZ Parris Frontiers in Cell and Developmental Biology 11, 1237673, 2023 | 3 | 2023 |
| Abstract A94: STAT3 antisense treatment decreases M2 macrophage infiltration and enhances the activity of checkpoint inhibitors in preclinical tumor models RD Woessner, P McCoon, S Grosskurth, P Lyne, K Bell, M Collins, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), A94-A94, 2015 | 2 | 2015 |
| Abstract A93: STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment R Woessner, P McCoon, K Bell, R DuPont, M Collins, D Lawson, ... Cancer Immunology Research 3 (10_Supplement), A93-A93, 2015 | 2 | 2015 |
| Chemokine analysis in patients with metastatic uveal melanoma suggests a role for CCL21 signaling in combined epigenetic therapy and checkpoint immunotherapy VR Sah, H Jespersen, J Karlsson, LM Nilsson, M Bergqvist, I Johansson, ... Cancer Research Communications 3 (5), 884-895, 2023 | 1 | 2023 |
| Using patient-derived xenografts as sources of 3D tumor sphere cultures to study autologous tumor-infiltrating lymphocytes in metastatic uveal melanoma V Sah, J Karlsson, V Bucher, RO Bagge, L Ny, L Nilsson, J Nilsson European Journal of Cancer 174, S45-S46, 2022 | 1 | 2022 |
| Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma VR Sah, H Jespersen, J Karlsson, MF Lindberg, LM Nilsson, L Ny, ... bioRxiv, 2021.02. 04.429575, 2021 | 1 | 2021 |
Jonas A NilssonSahlgrenska Center for Cancer Research (SE) and Harry Perkins Institute of Medical Research (AU)在 surgery.gu.se 的电子邮件经过验证
